On March 7, 2024, Portage Biotech Inc. was notified by Nasdaq that it is not meeting the $1.00 minimum bid price requirement for continued listing, with a compliance deadline set until September 3, 2024. The company intends to monitor the situation and may take steps to regain compliance to avoid potential delisting.